Retrospective Study on Data Aiming to Establish a Prediction Score for Return Home at the Time of Admission to a Multidisciplinary Medical Department (SCORDOM

Continuity of Patient Care Clinical Trial

— SCORDOM  

Official title:

Retrospective Study on Data Aiming to Establish a Prediction Score for Return Home at the Time of Admission to a Multidisciplinary Medical Department

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06288295
• Other study ID #: Etude SCORDOM
• Status: Completed
• Start date: October 1, 2021
• Est. completion date: February 28, 2023

Study information

• Verified date: February 2024
• Source: Elsan
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this observational study is to define clinical, biological and socio-cultural criteria, from the very first days of hospitalization on the multidisciplinary medicine department, to guide the patient's discharge from hospital (return to home when discharged from hospital).

The data collected will be those contained in the medical records of patients over 60 years of age who were admitted to the multidisciplinary medical department between October 2021 and February 2022 and between October 2022 and February 2023.

This study also aims at developing and validating a predictive score of orientation at the end of hospitalisation.

Participants are patients previously hospitalized. They will be informed about the study by post and will be able to object to the use of his or her data.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 600
• Est. completion date: February 28, 2023
• Est. primary completion date: February 28, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

For the development of the score:

1. All patients over 60 years of age admitted to the multidisciplinary medical department in the investigating center between October 2021 and February 2022.

2. Patients for whom data of interest to this study are available in medical records.

For score validation :

1. All patients aged over 60 admitted to the multidisciplinary medicine department of the investigating center between October 2022 and February 2023.

2. Patients for whom data of interest to this study are available in medical records.

Exclusion Criteria:

1. Patients transferred from an intensive care or continuing care unit

2. Patients in palliative care

3. Patients residing in an EHPAD (establishment for the elderly) or nursing home prior to hospitalization

4. Patients without a minimum blood test on admission (blood test less than 48 hours old)

5. Patients whose reason for hospitalization is due to COVID

6. Patients who have objected to the use of their personal data

Related Conditions & MeSH terms

• Continuity of Patient Care

Locations

Country	Name	City	State
France	Hôpital Privé Nancy Lorraine	Nancy

Sponsors (1)

Lead Sponsor	Collaborator
Elsan

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients with a return to home after hospitalization and with similar clinical parameters, similar age category, similar pathology and similar biological parameters	Data collected among hospital data from october 2021 to february 2022. Clinical parameters measured: age, confusional syndrome, fever, eschar, blood pressure, etc; biological paremeters: (blood test performed in the last 2 days before discharge: albuminemia, natremia, protein C, Creatinemy, hemoglobinemy)	Hospital stay, up to 3 weeks
Secondary	Number of patients with a return to home after hospitalization and with similar clinical parameters, similar age category, similar pathology and similar biological parameters	Data collected among hospital data from october 2022 to february 2023. Clinical parameters measured: age, confusional syndrome, fever, eschar, blood pressure, etc; biological paremeters: (blood test performed in the last 2 days before discharge: albuminemia, natremia, protein C, Creatinemy, hemoglobinemy)	Hospital stay, up to 3 weeks